David C. Paul is Chairman at GLOBUS MEDICAL INC (GMED). They have made 7 open-market trades across 1 company since 2012, most recently 2025-12-08.
CIK 0001555391
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GMED | 60,417 | $5.3M |
Shares reported on the most recent Form 4, priced at the 2025-12-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GMED | SELL | 2018-09-24 | 2018-09-26 | $54.30 | $190.6M | -10.5% | -7.0% | -23.8% |
| GMED | SELL | 2018-07-17 | 2018-07-19 | $52.95 | $724K | -2.5% | -3.1% | +4.6% |
| GMED | SELL | 2018-04-30 | 2018-04-30 | $51.81 | $3.8M | -2.4% | +9.3% | -1.8% |
| GMED | SELL | 2018-04-27 | 2018-04-30 | $51.78 | $1.5M | -2.4% | +9.3% | -1.8% |
| GMED | SELL | 2018-04-26 | 2018-04-30 | $51.81 | $51.5M | -2.4% | +9.3% | -1.8% |
| GMED | SELL | 2018-04-26 | 2018-04-30 | $51.81 | $35.6M | -2.4% | +9.3% | -1.8% |
| GMED | SELL · 10b5-1 | 2015-03-18 | 2015-03-20 | $25.00 | $48.0M | -7.9% | -2.9% | -2.9% |
| GMED | SELL | 2012-08-08 | 2012-08-10 | $11.16 | $33.9M | -7.9% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.